|
 |
|
Home > Analysis of the Global In Vitro Diagnostics Market
|
Analysis of the Global In Vitro Diagnostics Market
|
 |
|
 |
Despite global economic and industry challenges, in vitro diagnostics (IVD) markets are growing robustly at double the rate of the global pharmaceutical industry. This research deliverable leverages primary research, secondary sources, and Frost & Sullivan’s proprietary database of global research. Market segments include immunochemistry, self-monitoring of blood glucose (SMBG), point-of-care testing (POCT), molecular diagnostics, hematology, clinical microbiology, and hemostasis. Regions include United States, Western Europe, Asia-Pacific, Latin America, and Eastern Europe. Each segment includes revenue forecasts for 2009 to 2017, market share, competitive landscape, and product analysis.
|
|
 |
|
|
|
|
|
|
|
Local PDF: $6000.00 Other Formats: Global PDF, DataPack
|
 |
|
|
|
|
|
|
|